Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 45
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

MoCHI: neural networks to fit interpretable models and quantify energies, energetic couplings, epistasis, and allostery from deep mutational scanning data

  • Faure, Andre J.
  • Lehner, Ben, 1978-
We present MoCHI, a tool to fit interpretable models using deep mutational scanning data. MoCHI infers free energy changes, as well as interaction terms (energetic couplings) for specified biophysical models, including from multimodal phenotypic data. When a user-specified model is unavailable, global nonlinearities (epistasis) can be estimated from the data. MoCHI also leverages ensemble, background-averaged epistasis to learn sparse models that can incorporate higher-order epistatic terms. MoCHI is freely available as a Python package ( https://github.com/lehner-lab/MoCHI ) relying on the PyTorch machine learning framework and allows biophysical measurements at scale, including the construction of allosteric maps of proteins., This work was funded by European Research Council (ERC) Advanced grant (883742), the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/https://doi.org/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A small molecule stabilizer rescues the surface expression of nearly all missense variants in a GPCR

  • Mighell, Taylor L.
  • Lehner, Ben, 1978-
Data de publicació electrònica: 22-09-2025, Reduced protein abundance is the most frequent mechanism by which rare missense variants cause disease. A promising therapeutic avenue for treating reduced abundance variants is pharmacological chaperones (PCs, also known as correctors or stabilizers), small molecules that bind to and stabilize target proteins. PCs have been approved as clinical treatments for specific variants, but protein energetics suggest their effects might be much more general. To comprehensively assess PC efficacy for variation in a given protein, it is necessary to first assign the molecular mechanism explaining all pathogenic variants, then measure the response to the PC. Here we establish such a framework for the vasopressin 2 receptor (V2R), a G-protein-coupled receptor in which loss-of-function variants cause nephrogenic diabetes insipidus (NDI). Our data show that more than half of NDI variants are poorly expressed, highlighting loss of stability as the major pathogenic mechanism. Treatment with a PC rescues the expression of 87% of destabilized variants. The non-rescued variants identify the drug's predicted binding site. Our results provide proof-of-principle that small molecule binding can rescue destabilizing variants throughout a protein's structure. The application of this principle to other proteins should allow the development of effective therapies for many different rare diseases., This work was funded by a European Research Council Advanced Grant (883742), Wellcome (220540/Z/20/A), the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. T.L.M. was funded by an EMBO fellowship (ALTF 113-2021). We thank all members of the Lehner Lab and J. Selent and T. Stepniewski for helpful discussions. We thank the CRG/UPF Flow Cytometry Unit for assistance with the sorting experiments.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

SUNi mutagenesis: Scalable and uniform nicking for efficient generation of variant libraries

  • Mighell, Taylor L.
  • Toledano, Ignasi
  • Lehner, Ben, 1978-
Multiplexed assays of variant effects (MAVEs) have made possible the functional assessment of all possible mutations to genes and regulatory sequences. A core pillar of the approach is generation of variant libraries, but current methods are either difficult to scale or not uniform enough to enable MAVEs at the scale of gene families or beyond. We present an improved method called Scalable and Uniform Nicking (SUNi) mutagenesis that combines massive scalability with high uniformity to enable cost-effective MAVEs of gene families and eventually genomes., This work was funded by a European Research Council (ERC) Advanced grant (883742), the Spanish Ministry of Science and Innovation (PID2020-118723GB-I00, EMBL Partnership, Severo Ochoa Centre of Excellence), the la Caixa Research Foundation (LCF/PR/HR21/52410004), the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. T.L.M. was funded by an EMBO long-term fellowship (ALTF 113-2021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation

  • Seuma, Mireia
  • Lehner, Ben, 1978-
  • Bolognesi, Benedetta
Multiplexed assays of variant effects (MAVEs) guide clinical variant interpretation and reveal disease mechanisms. To date, MAVEs have focussed on a single mutation type-amino acid (AA) substitutions-despite the diversity of coding variants that cause disease. Here we use Deep Indel Mutagenesis (DIM) to generate a comprehensive atlas of diverse variant effects for a disease protein, the amyloid beta (Aβ) peptide that aggregates in Alzheimer's disease (AD) and is mutated in familial AD (fAD). The atlas identifies known fAD mutations and reveals that many variants beyond substitutions accelerate Aβ aggregation and are likely to be pathogenic. Truncations, substitutions, insertions, single- and internal multi-AA deletions differ in their propensity to enhance or impair aggregation, but likely pathogenic variants from all classes are highly enriched in the polar N-terminal region of Aβ. This comparative atlas highlights the importance of including diverse mutation types in MAVEs and provides important mechanistic insights into amyloid nucleation., M.S. was supported by a fellowship from Agencia de Gestio d’Ajuts Universitaris i de Recerca (2019FI_B 01311). Work in the lab of BB and BL is supported by the la Caixa Research Foundation project ‘DeepAmyloids’ (LCF/PR/HR21/52410004). Work in the lab of BB is also supported by the Spanish Ministry of Science, Innovation and Universities (PID2021-127761OB-I00 and RYC2020-028861-I, funded by MCIN/AEI/ 10.13039/501100011033, “ERDF A way of making Europe” and “ESF Investing in your future”) and the CERCA Program/Generalitat de Catalunya. Work in the lab of BL is also supported by a European Research Council (ERC) Advanced Grant (‘Mutanomics’ 883742), the Spanish Ministry of Science, Innovation and Universities (PID2020-118723GB-I00), the Bettencourt Schueller Foundation, the AXA Research Foundation, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership and the Centro de Excelencia Severo Ochoa. We thank the Chernoff lab for providing strains and plasmids and the CRG Genomics core technology for sequencing. We also thank Andre Faure and Marta Badia for advice on data analysis, Leire Moriones for assistance with validation experiments and Xavier Salvatella and Carla Garcia for discussing our data.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Genetics, energetics, and allostery in proteins with randomized cores and surfaces

  • Escobedo, Albert
  • Voigt, Gesa
  • Faure, Andre J.
  • Lehner, Ben, 1978-
A lack of systematic experimental data limits our understanding of protein evolution. In this study, we experimentally characterized proteins with randomized sequences. Vast numbers of amino acid combinations constitute stable protein cores and surfaces. However, alternative cores frequently disrupt protein function by indirect allosteric effects. Both protein stability and binding can be predicted using simple additive energy models with a small contribution from pairwise energetic couplings. Indeed, energy models trained on one protein can predict functional cores and surfaces across more than a billion years of evolution, with only rare energetic couplings that we experimentally identify limiting the transplantation of cores between highly diverged proteins. Our results reveal the simple energetic architecture of proteins and suggest that allostery is an important constraint on sequence evolution., This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 883742), “la Caixa” Foundation under the grant agreement HR21-00375, the Bettencourt Schueller Foundation, the AXA Research Fund (AXA Chair in Risk prediction in age-related diseases), the Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia (AGAUR, 2017 SGR 1322), and Wellcome (Grant reference: 220540/Z/20/A, 'Wellcome Sanger Institute Quinquennial Review 2021-2026').
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

  • Baeza Centurión, Pablo, 1989-
  • Miñana Gómez, Belén
  • Faure, Andre J.
  • Thompson, Mike
  • Bonnal, Sophie
  • Quarantani, Gioia
  • Clarke, Joseph
  • Lehner, Ben, 1978-
  • Valcárcel, J. (Juan)
While altered pre-mRNA splicing is a frequent mechanism by which genetic variants cause disease, the regulatory architecture of human exons remains poorly understood. Antisense oligonucleotides (AONs) that target pre-mRNA splicing have been approved as therapeutics for various pathologies including patient-customised treatments for rare diseases, but AON discovery is currently slow and expensive, limiting the wider adoption of the approach. Here we show that deep indel mutagenesis (DIM) -which can be made experimentally at very low cost - provides an efficient strategy to chart the regulatory landscape of human exons and rapidly identify candidate splicing-modulating oligonucleotides. DIM reveals autonomous effects of insertions, while systematic deletion scans delineate the checkerboard architecture of sequential enhancers and silencers in a model alternative exon. The results also suggest a mechanism for repression of transmembrane domain-encoding exons and for the generation of microexons. Leveraging deep learning tools, we provide a resource, DANGO, that predicts the splicing regulatory landscape of all human exons and can help to identify effective splicing-modulating antisense oligonucleotides., This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreements 670146 and 883742) and from the European Union's Horizon Europe under the grant agreement No 101071936. We also acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. We received funding from the Spanish State Research Agency (PID2020-114630GB-I00/AEI/10.13039/501100011033), LCF/PR/HR21/52410004, EMBL Partnership, the Bettencourt Schueller Foundation, the AXA Research Fund, and Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322). GQ was supported by PRE2022-102744, financed by MCIN/AEI/10.13039/501100011033 and FSE + . J.C. is funded by the BBSRC DTP (Bio-technology and Biological Sciences Research Council, Biosciences Doctoral Training Programme, Cambridge, UK. The Genotype-Tissue Expression (GTEx) data used for the analyses described in this manu-script were obtained from the GTEx Portal on May 8, 2018 and dbGaP accession number phs000424.v7.p2 on May 8, 2018. The GTEx Project was supported by the Common Fund of the Office of the Director of the NIH and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Site-saturation mutagenesis of 500 human protein domains

  • Beltran, Antoni
  • Jiang, Xiang'er
  • Shen, Yue
  • Lehner, Ben, 1978-
Missense variants that change the amino acid sequences of proteins cause one-third of human genetic diseases1. Tens of millions of missense variants exist in the current human population, and the vast majority of these have unknown functional consequences. Here we present a large-scale experimental analysis of human missense variants across many different proteins. Using DNA synthesis and cellular selection experiments we quantify the effect of more than 500,000 variants on the abundance of more than 500 human protein domains. This dataset reveals that 60% of pathogenic missense variants reduce protein stability. The contribution of stability to protein fitness varies across proteins and diseases and is particularly important in recessive disorders. We combine stability measurements with protein language models to annotate functional sites across proteins. Mutational effects on stability are largely conserved in homologous domains, enabling accurate stability prediction across entire protein families using energy models. Our data demonstrate the feasibility of assaying human protein variants at scale and provides a large consistent reference dataset for clinical variant interpretation and training and benchmarking of computational methods., A.B. and B.L. were funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. A.B. was funded by an EMBO fellowship (ALTF 183-2020) and by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 101030961. X.J. and Y.S. were funded by the National Natural Science Foundation of China (32322047) and Jiangsu Provincial Department of Science and Technology (BM2023009). We thank all members of the Lehner laboratory for helpful discussions and suggestions.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The allosteric landscape of the Src kinase

  • Beltran, Antoni
  • Naqvi, Mohsin M.
  • Faure, Andre J.
  • Lehner, Ben, 1978-
Enzymes catalyze the reactions of life and are the targets of many drugs. Most inhibitors bind conserved active sites, frequently lacking specificity. Targeting allosteric sites can increase specificity, reduce toxicity, and allow fine-tuning of activity; however, most allosteric sites in enzymes are unmapped. Here, we present a comprehensive experimental allosteric map of the Src protein kinase. We quantify the effects of more than 50,000 single and double amino acid substitutions on activity and abundance and use thermodynamic modeling to disentangle changes in fold stability and catalysis. The comprehensive energy landscape reveals that allostery across the kinase domain is extensive, directionally biased, and modulated by its regulatory domains. Inhibitory-but not activating-allosteric mutations show a strong distance-dependent decay away from the active site. Using the map, we identify multiple potentially druggable allosteric sites not previously reported in Src or other kinases. Our results establish a framework for comprehensive mapping of allostery in kinases and other enzymes important for medicine and biotechnology., This work was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), the CERCA Program/Generalitat de Catalunya, and Wellcome (Grant reference: 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026”). A.B. was funded by an EMBO (ALTF 183-2020) and Marie Skłodowska-Curie (101030961) fellowship. A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI /10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). We thank all members of the Lehner laboratory for helpful discussions and suggestions.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Allosteric and energetic remodeling of a PDZ domain by protein domain extensions

  • Hidalgo-Carcedo, Cristina
  • Faure, Andre J.
  • Martí-Aranda, Aina
  • Zarin, Taraneh
  • Lehner, Ben, 1978-
Many functions of proteins are performed by independently folding structural units called domains. These domains are structurally conserved but not identical in different proteins. Here, to understand the consequences for regulation and evolvability of domain extensions, we quantify the energetic effects of two extensions in a model protein domain. Quantifying abundance and ligand binding for >190,000 protein variants allows us to measure the free energy changes for mutations throughout a PDZ domain and ~7000 energetic couplings between these mutations and two domain extensions. Both a structured extension and a more dynamic extension substantially but specifically re-shape the energy landscape. In particular, deleting an a-helix alters the energetic consequences of >400 mutations in >50 sites on fold stability or binding energy, and the effects of >300 allosteric mutations, including at solvent-accessible surface sites. Extending or pruning the domain therefore reshapes its energetic and allosteric landscape, adding and removing opportunities for the allosteric control of protein function., These results are part of project PID2022-142210NA-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE. This work has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 883742), the Spanish State Research Agency (PID2020-118723GB-I00/ AEI / 10.13039/501100011033), Wellcome (220540/Z/20/A), Departament de Recerca i Universitats de la Generalitat de Catalunya (AGAUR, 2021-SGR2021-01226). A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). A.M.A. was funded in part by a fellowship from 'laCaixa' Foundation (ID 100010434, fellowship code B006052). T.Z. was funded by a EMBO Long-term Postdoctoral Fellowship (ALTF 525-2021) and the European Union's Horizon Europe under the grant agreement No 101068134. We acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. We acknowledge all members of the Lehner lab for feedback during the project, particularly Toni Beltran and Albert Escobedo for advice with data analysis.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The energetic and allosteric landscape for KRAS inhibition

  • Weng, Chenchun
  • Faure, Andre J.
  • Escobedo, Albert
  • Lehner, Ben, 1978-
Thousands of proteins have been validated genetically as therapeutic targets for human diseases1. However, very few have been successfully targeted, and many are considered 'undruggable'. This is particularly true for proteins that function via protein-protein interactions-direct inhibition of binding interfaces is difficult and requires the identification of allosteric sites. However, most proteins have no known allosteric sites, and a comprehensive allosteric map does not exist for any protein. Here we address this shortcoming by charting multiple global atlases of inhibitory allosteric communication in KRAS. We quantified the effects of more than 26,000 mutations on the folding of KRAS and its binding to six interaction partners. Genetic interactions in double mutants enabled us to perform biophysical measurements at scale, inferring more than 22,000 causal free energy changes. These energy landscapes quantify how mutations tune the binding specificity of a signalling protein and map the inhibitory allosteric sites for an important therapeutic target. Allosteric propagation is particularly effective across the central β-sheet of KRAS, and multiple surface pockets are genetically validated as allosterically active, including a distal pocket in the C-terminal lobe of the protein. Allosteric mutations typically inhibit binding to all tested effectors, but they can also change the binding specificity, revealing the regulatory, evolutionary and therapeutic potential to tune pathway activation. Using the approach described here, it should be possible to rapidly and comprehensively identify allosteric target sites in many proteins., This work was funded by European Research Council (ERC) Advanced grant (883742), the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. C.W. was funded by an EMBO long-term fellowship (ALTF 881-2020). A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). We thank all members of the Lehner laboratory for helpful discussions and suggestions. We thank the CRG Genomics Unit for sequencing and the Protein Technologies Unit for assistance with the SPR measurements.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The impact of rare germline variants on human somatic mutation processes

  • Vali-Pour, Mischan
  • Solip, Park
  • Espinosa-Carrasco, José
  • Ortiz-Martínez, Daniel
  • Lehner, Ben, 1978-
  • Supek, Fran
Somatic mutations are an inevitable component of ageing and the most important cause of cancer. The rates and types of somatic mutation vary across individuals, but relatively few inherited influences on mutation processes are known. We perform a gene-based rare variant association study with diverse mutational processes, using human cancer genomes from over 11,000 individuals of European ancestry. By combining burden and variance tests, we identify 207 associations involving 15 somatic mutational phenotypes and 42 genes that replicated in an independent data set at a false discovery rate of 1%. We associate rare inherited deleterious variants in genes such as MSH3, EXO1, SETD2, and MTOR with two phenotypically different forms of DNA mismatch repair deficiency, and variants in genes such as EXO1, PAXIP1, RIF1, and WRN with deficiency in homologous recombination repair. In addition, we identify associations with other mutational processes, such as APEX1 with APOBEC-signature mutagenesis. Many of the genes interact with each other and with known mutator genes within cellular sub-networks. Considered collectively, damaging variants in the identified genes are prevalent in the population. We suggest that rare germline variation in diverse genes commonly impacts mutational processes in somatic cells., M.V.P. was supported by a Spanish Ministry of Science and Innovation FPI Fellowship (ref.: PRE2018-084410). Work in the lab of B.L. is funded by European Research Council (ERC) Advanced (883742) and Consolidator (616434) grants, the Spanish Ministry of Science and Innovation (BFU2017-89488-P, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. Work in the lab of F.S. is funded by the ERC Starting Grant HYPER-INSIGHT (757700), the Horizon2020 RIA grant DECIDER (965193), Spanish Ministry of Science and Innovation grant REPAIRSCAPE (PID2020-118795GB-I00), the EMBO YIP program, the Severo Ochoa Centre of Excellence award to IRB Barcelona, and the CERCA Program/Generalitat de Catalunya.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Allostery is a widespread cause of loss-of-function variant pathogenicity

  • Liao, Xiaotian
  • Lehner, Ben, 1978-
Allosteric communication between non-contacting sites in proteins plays a fundamental role in biological regulation and drug action. While allosteric gain-of-function variants are known drivers of oncogene activation, the broader importance of allostery in genetic disease and protein evolution is less clear. Here, we introduce a comparative framework that disentangles functional disruption by mutations from protein destabilization. Applying this framework across diverse datasets-ranging from paired experimental measurements of abundance and activity to proteome-wide comparisons of evolutionary fitness and biophysical stability predictions-we provide evidence that allostery is a widespread cause of loss-of-function variant pathogenicity in human genetic diseases. In addition, our analyses reveal a conserved distance-dependent decay of allosteric mutational effects outside of protein active sites. As an important mechanism of pathogenicity, allostery needs to be better mapped, understood, and predicted across the human proteome., Work in the lab of B.L. was funded by Wellcome (Grant reference: 220540/Z/20/A, 'Wellcome Sanger Institute Quinquennial Review 2021-2026'), a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Center of Excellence), Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR, 2021 SGR 01226), and the CERCA Program/Generalitat de Catalunya. X.L is funded by the Wellcome Sanger Institute PhD Graduate program.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules

  • Toledano, Ignasi
  • Supek, Fran
  • Lehner, Ben
Premature termination codons (PTCs) cause ~10-20% of inherited diseases and are a major mechanism of tumor suppressor gene inactivation in cancer. A general strategy to alleviate the effects of PTCs would be to promote translational readthrough. Nonsense suppression by small molecules has proven effective in diverse disease models, but translation into the clinic is hampered by ineffective readthrough of many PTCs. Here we directly tackle the challenge of defining drug efficacy by quantifying the readthrough of ~5,800 human pathogenic stop codons by eight drugs. We find that different drugs promote the readthrough of complementary subsets of PTCs defined by local sequence context. This allows us to build interpretable models that accurately predict drug-induced readthrough genome-wide, and we validate these models by quantifying endogenous stop codon readthrough. Accurate readthrough quantification and prediction will empower clinical trial design and the development of personalized nonsense suppression therapies., Work in the Supek laboratory was supported by an ERC StG ‘HYPER-INSIGHT’ (757700) and ERC CoG ‘STRUCTOMATIC’ (101088342), Horizon2020 project ‘DECIDER’ (965193), Horizon Europe project ‘LUCIA’ (101096473), Spanish government project ‘REPAIRSCAPE’, CaixaResearch project ‘POTENT-IMMUNO’ (HR22-00402), an ICREA professorship to F.S., the SGR funding from the Catalan government and a Novo Nordisk Fonden starting package. Work in the Lehner laboratory was funded by European Research Council (ERC) Advanced (grant 883742) and Consolidator (grant 616434), the Spanish Ministry of Science and Innovation (BFU2017-89488-P, EMBL Partnership, Severo Ochoa Center of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. The authors would like to thank the four members E. Ramírez, A. Bote, E. Julià and Ò. Fornàs of the Flow Cytometry CRG Core Unit for their support and time, together with G. Palou (IRB) for his help in retrieving the transcript sequences from the Ensembl database and all members of the Supek and Lehner laboratories for helpful discussions and suggestions.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The impact of rare germline variants on human somatic mutation processes

  • Vali-Pour, Mischan
  • Lehner, Ben, 1978-
  • Supek, Fran
Somatic mutations are an inevitable component of ageing and the most important cause of cancer. The rates and types of somatic mutation vary across individuals, but relatively few inherited influences on mutation processes are known. We perform a gene-based rare variant association study with diverse mutational processes, using human cancer genomes from over 11,000 individuals of European ancestry. By combining burden and variance tests, we identify 207 associations involving 15 somatic mutational phenotypes and 42 genes that replicated in an independent data set at a false discovery rate of 1%. We associate rare inherited deleterious variants in genes such as MSH3, EXO1, SETD2, and MTOR with two phenotypically different forms of DNA mismatch repair deficiency, and variants in genes such as EXO1, PAXIP1, RIF1, and WRN with deficiency in homologous recombination repair. In addition, we identify associations with other mutational processes, such as APEX1 with APOBEC-signature mutagenesis. Many of the genes interact with each other and with known mutator genes within cellular sub-networks. Considered collectively, damaging variants in the identified genes are prevalent in the population. We suggest that rare germline variation in diverse genes commonly impacts mutational processes in somatic cells., M.V.P. was supported by a Spanish Ministry of Science and Innovation FPI Fellowship (ref.: PRE2018-084410). Work in the lab of B.L. is funded by European Research Council (ERC) Advanced (883742) and Consolidator (616434) grants, the Spanish Ministry of Science and Innovation (BFU2017-89488-P, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. Work in the lab of F.S. is funded by the ERC Starting Grant HYPER-INSIGHT (757700), the Horizon2020 RIA grant DECIDER (965193), Spanish Ministry of Science and Innovation grant REPAIRSCAPE (PID2020-118795GB-I00), the EMBO YIP program, the Severo Ochoa Centre of Excellence award to IRB Barcelona, and the CERCA Program/Generalitat de Catalunya. We thank Solip Park for method consultations, comments, and discussions.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Deep indel mutagenesis reveals the impact of amino acid insertions and deletions on protein stability and function

  • Topolska, Magdalena
  • Beltran, Antoni
  • Lehner, Ben, 1978-
Amino acid insertions and deletions (indels) are an abundant class of genetic variants. However, compared to substitutions, the effects of indels on protein stability are not well understood. To better understand indels here we analyse new and existing large-scale deep indel mutagenesis (DIM) of structurally diverse proteins. The effects of indels on protein stability vary extensively among and within proteins and are not well predicted by existing computational methods. To address this shortcoming we present INDELi, a series of models that combine experimental or predicted substitution effects and secondary structure information to provide good prediction of the effects of indels on both protein stability and pathogenicity. Moreover, quantifying the effects of indels on protein-protein interactions suggests that insertions can be an important class of gain-of-function variants. Our results provide an overview of the impact of indels on proteins and a method to predict their effects genome-wide., This work was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Programme/Generalitat de Catalunya. M.T. was funded by a Spanish Ministry of Science and Innovation Severo-Ochoa fellowship PRE2020-093984-SO. T.B. was funded by an EMBO (ALTF 183-2020) and Marie Skłodowska-Curie (101030961) fellowship.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Massively parallel genetic perturbation suggests the energetic structure of an amyloid-β transition state

  • Arutyunyan, Anna
  • Seuma, Mireia
  • Faure, Andre J.
  • Bolognesi, Benedetta
  • Lehner, Ben, 1978-
Amyloid aggregates are pathological hallmarks of many human diseases, but how soluble proteins nucleate to form amyloids is poorly understood. Here, we use combinatorial mutagenesis, a kinetic selection assay, and machine learning to massively perturb the energetics of the nucleation reaction of amyloid-β (Aβ42), the protein that aggregates in Alzheimer's disease. In total, we measure the nucleation rates of >140,000 variants of Aβ42 to accurately quantify the changes in free energy of activation of the reaction for all possible amino acid substitutions in a protein and, in addition, to quantify >600 energetic interactions between mutations. Strong energetic couplings suggest that the Aβ42 nucleation reaction transition state is structured in a short C-terminal region, providing a structural model for the reaction that may initiate Alzheimer's disease. Using this approach it should be possible to reveal the energetic structures of additional amyloid transition states and, in combination with additional selection assays, protein transition states more generally., This work was funded by the La Caixa Research Foundation project “DeepAmyloids” (LCF/PR/HR21/52410004). Work in the lab of B.B. was also funded by the Spanish Ministry of Science, Innovation and Universities (PID2021-127761OB-I00 and RYC2020-028861-I funded by MCIN/AEI/10.13039/501100011033, “ERDF A way of making Europe” and “ESF Investing in your future”) and by the European Union (ERC Consolidator, Glam-MAP, 101125484). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. Work in the lab of B.L. was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), the CERCA Program/Generalitat de Catalunya, and Wellcome (grant reference: 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026”). M.S. was funded by a fellowship from Agencia de Gestio d’Ajuts Universitaris i de Recerca (2019FI_B 01311). A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The genetic architecture of protein interaction affinity and specificity

  • Bendel, Alexandra M.
  • Faure, Andre J.
  • Klein, Dominique
  • Shimada, Kenji
  • Lyautey, Romane
  • Schiffelholz, Nicole
  • Kempf, Georg
  • Cavadini, Simone
  • Lehner, Ben, 1978-
  • Diss, Guillaume
The encoding and evolution of specificity and affinity in protein-protein interactions is poorly understood. Here, we address this question by quantifying how all mutations in one protein, JUN, alter binding to all other members of a protein family, the 54 human basic leucine zipper transcription factors. We fit a global thermodynamic model to the data to reveal that most affinity changing mutations equally affect JUN's affinity to all its interaction partners. Mutations that alter binding specificity are relatively rare but distributed throughout the interaction interface. Specificity is determined both by features that promote on-target interactions and by those that prevent off-target interactions. Approximately half of the specificity-defining residues in JUN contribute both to promoting on-target binding and preventing off-target binding. Nearly all specificity-altering mutations in the interaction interface are pleiotropic, also altering affinity to all partners. In contrast, mutations outside the interface can tune global affinity without affecting specificity. Our results reveal the distributed encoding of specificity and affinity in an interaction interface and how coiled-coils provide an elegant solution to the challenge of optimizing both specificity and affinity in a large protein family.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Mapping the energetic and allosteric landscapes of protein binding domains.

  • Faure, Andre J.
  • Domingo Espinós, Júlia, 1991-
  • Schmiedel, Jörn M.
  • Hidalgo-Carcedo, Cristina
  • Diss, Guillaume
  • Lehner, Ben, 1978-
Allosteric communication between distant sites in proteins is central to biological regulation but still poorly characterized, limiting understanding, engineering and drug development1-6. An important reason for this is the lack of methods to comprehensively quantify allostery in diverse proteins. Here we address this shortcoming and present a method that uses deep mutational scanning to globally map allostery. The approach uses an efficient experimental design to infer en masse the causal biophysical effects of mutations by quantifying multiple molecular phenotypes-here we examine binding and protein abundance-in multiple genetic backgrounds and fitting thermodynamic models using neural networks. We apply the approach to two of the most common protein interaction domains found in humans, an SH3 domain and a PDZ domain, to produce comprehensive atlases of allosteric communication. Allosteric mutations are abundant, with a large mutational target space of network-altering 'edgetic' variants. Mutations are more likely to be allosteric closer to binding interfaces, at glycine residues and at specific residues connecting to an opposite surface within the PDZ domain. This general approach of quantifying mutational effects for multiple molecular phenotypes and in multiple genetic backgrounds should enable the energetic and allosteric landscapes of many proteins to be rapidly and comprehensively mapped., This work was funded by European Research Council (ERC) Advanced (883742) and Consolidator (616434) grants, the Spanish Ministry of Science and Innovation (PID2020-118723GB-I00, BFU2017-89488-P, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. J.M.S. was supported by an EMBO Long-Term Fellowship (ALTF 857-2016) and a Marie Skłodowska-Curie Fellowship (752809, EU Commission Horizon 2020)
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Massive experimental quantification allows interpretable deep learning of protein aggregation

  • Thompson, Mike
  • Martín, Mariano
  • Sanmartín Olmo, Trinidad
  • Rajesh, Chandana
  • Koo, Peter K.
  • Bolognesi, Benedetta
  • Lehner, Ben, 1978-
Protein aggregation is a pathological hallmark of more than 50 human diseases and a major problem for biotechnology. Methods have been proposed to predict aggregation from sequence, but these have been trained and evaluated on small and biased experimental datasets. Here we directly address this data shortage by experimentally quantifying the aggregation of >100,000 protein sequences. This unprecedented dataset reveals the limited performance of existing computational methods and allows us to train CANYA, a convolution-attention hybrid neural network that accurately predicts aggregation from sequence. We adapt genomic neural network interpretability analyses to reveal CANYA's decision-making process and learned grammar. Our results illustrate the power of massive experimental analysis of random sequence-spaces and provide an interpretable and robust neural network model to predict aggregation., This work received support from the following: “La Caixa” Foundation (ID 100010434) under grant agreement LCF/PR/HR21/52410004 (B.L.); European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme grant agreement 883742 (B.L.); AXA Research Fund AXA Chair in Risk prediction in age-related diseases (B.L.); Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and the European Social Funds 2017 SGR 1322 (B.L.); Bettencourt Schueller Foundation (B.L.); PID2023-146685NB-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE; Wellcome 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026” (B.L.); Spanish Ministry of Science, Innovation and Universities PID2021-127761OB-I00 (B.B.) RYC2020-028861-I funded by MCIN/AEI/ 10.13039/501100011033 “ERDF A way of making Europe” and “ESF Investing in your future” (B.B.); European Union (ERC Consolidator, Glam-MAP, 101125484) (B.B.); EMBO Fellowship ALTF 266-2023 (M.T.); NIH grant R01HG012131 (P.K. and C.R.); and NIH grant R01GM149921 (P.K. and C.R.).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The genetic architecture of protein stability

  • Faure, Andre J.
  • Martí Aranda, Aina
  • Hidalgo-Carcedo, Cristina
  • Beltran, Antoni
  • Schmiedel, Jörn M.
  • Lehner, Ben, 1978-
There are more ways to synthesize a 100-amino acid (aa) protein (20100) than there are atoms in the universe. Only a very small fraction of such a vast sequence space can ever be experimentally or computationally surveyed. Deep neural networks are increasingly being used to navigate high-dimensional sequence spaces1. However, these models are extremely complicated. Here, by experimentally sampling from sequence spaces larger than 1010, we show that the genetic architecture of at least some proteins is remarkably simple, allowing accurate genetic prediction in high-dimensional sequence spaces with fully interpretable energy models. These models capture the nonlinear relationships between free energies and phenotypes but otherwise consist of additive free energy changes with a small contribution from pairwise energetic couplings. These energetic couplings are sparse and associated with structural contacts and backbone proximity. Our results indicate that protein genetics is actually both rather simple and intelligible., This work was funded by a European Research Council Advanced Grant (883742), the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). A.M.-A. was funded by a fellowship from ”laCaixa” Foundation (ID 100010434, fellowship code B006052). We thank all members of the Lehner Lab for helpful discussions and suggestions.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers

  • Park, Solip
  • Supek, Fran
  • Lehner, Ben, 1978-
The classic two-hit model posits that both alleles of a tumor suppressor gene (TSG) must be inactivated to cause cancer. In contrast, for some oncogenes and haploinsufficient TSGs, a single genetic alteration can suffice to increase tumor fitness. Here, by quantifying the interactions between mutations and copy number alterations (CNAs) across 10,000 tumors, we show that many cancer genes actually switch between acting as one-hit or two-hit drivers. Third order genetic interactions identify the causes of some of these switches in dominance and dosage sensitivity as mutations in other genes in the same biological pathway. The correct genetic model for a gene thus depends on the other mutations in a genome, with a second hit in the same gene or an alteration in a different gene in the same pathway sometimes representing alternative evolutionary paths to cancer., This work was funded by the European Research Council (ERC) Starting grant (HYPER-INSIGHT, 757700) to F.S. and ERC Consolidator (IR-DC, 616434) and Advanced (MUTANOMICS, 883742) grants to B.L. F.S. and B.L. are funded by the ICREA Research Professor program. S.P., F.S., and B.L. acknowledge the support of the Severo Ochoa Centres of Excellence program to the CNIO, IRB Barcelona, and to the CRG (MCIN/AEI/10.13039/50110001103), respectively. B.L. and F.S. Work is funded with the grants BFU2017-89488-P and RegioMut BFU2017-89833-P (MCIN/AEI /10.13039/501100011033/FEDER “A way to make Europe”), respectively. B.L. is further supported by the Bettencourt Schueller Foundation, the Agencia de Gestio d’Ajuts Universitaris i de Recerca (2017 SGR 1322), and the Centres de Recerca de Catalunya (CERCA) program/Generalitat de Catalunya. B.L. also acknowledges the support of the Spanish Ministry of Economy, Industry, and Competitiveness to the European Molecular Biology Laboratory (EMBL) partnership. The results shown here are in whole or part based upon data generated by the TCGA Research Network.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Guidelines for releasing a variant effect predictor

  • Livesey, Benjamin J.
  • Badonyi, Mihaly
  • Dias, Mafalda
  • Frazer, Jonathan
  • Kumar, Sushant
  • Lindorff-Larsen, Kresten
  • McCandlish, David M.
  • Orenbuch, Rose
  • Shearer, Courtney A.
  • Muffley, Lara
  • Foreman, Julia
  • Glazer, Andrew M.
  • Lehner, Ben, 1978-
  • Marks, Debora S.
  • Roth, Frederick P.
  • Rubin, Alan F.
  • Starita, Lea M.
  • Marsh, Joseph A.
Computational methods for assessing the likely impacts of mutations, known as variant effect predictors (VEPs), are widely used in the assessment and interpretation of human genetic variation, as well as in other applications like protein engineering. Many different VEPs have been released, and there is tremendous variability in their underlying algorithms, outputs, and the ways in which the methodologies and predictions are shared. This leads to considerable difficulties for users trying to navigate the selection and application of VEPs. Here, to address these issues, we provide guidelines and recommendations for the release of novel VEPs., MD and J Frazer are supported by the Spanish Ministry of Science and Innovation (PID2022-140793NA-I00). KLL received funding from the Novo Nordisk Foundation (NNF18OC0033950). DMM received funding from the National Institutes of Health (NIH) (R35GM133613). RO and DSM are supported by the Chan Zuckerberg Initiative Neurodegeneration Challenge Network (CZI2018-191853). LM, LMS, and FPR received funding from the NIH (RM1HG010461), and FPR also received funding from NIH grant UM1HG011989. J Foreman received funding from the Wellcome Trust (WT223718/Z/21/Z). AMG received funding from the NIH (R35GM150465). BL received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 883742). DSM received funding from the NIH (1R01CA260415). AFR received funding from the NIH (UM1HG011969, RM1HG010461, R01HG013025) and grant funding from the Australian Government. JAM is supported by the ERC (grant agreement No. 101001169) and by the Medical Research Council (MRC) Human Genetics Unit core grant (MC_UU_00035/9).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The allosteric landscape of the Src kinase

  • Beltran, Antoni
  • Naqvi, Mohsin M.
  • Faure, Andre J.
  • Lehner, Ben
18 páginas, 6 figuras., Enzymes catalyze the reactions of life and are the targets of many drugs. Most inhibitors bind conserved active sites, frequently lacking specificity. Targeting allosteric sites can increase specificity, reduce toxicity, and allow fine-tuning of activity; however, most allosteric sites in enzymes are unmapped. Here, we present a comprehensive experimental allosteric map of the Src protein kinase. We quantify the effects of more than 50,000 single and double amino acid substitutions on activity and abundance and use thermodynamic modeling to disentangle changes in fold stability and catalysis. The comprehensive energy landscape reveals that allostery across the kinase domain is extensive, directionally biased, and modulated by its regulatory domains. Inhibitory-but not activating-allosteric mutations show a strong distance-dependent decay away from the active site. Using the map, we identify multiple potentially druggable allosteric sites not previously reported in Src or other kinases. Our results establish a framework for comprehensive mapping of allostery in kinases and other enzymes important for medicine and biotechnology., This work was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LC F/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), the CERCA Program/Generalitat de Catalunya, and Wellcome (Grant reference: 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026”). A.B. was funded by an EMBO (ALT F 183-2020) and Marie Skłodowska-Curie (101030961) fellowship. A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI /10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). We thank all members of the Lehner laboratory for helpful discussions and suggestions., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation

  • Seuma, Mireia
  • Lehner, Ben, 1978-
  • Bolognesi, Benedetta
Multiplexed assays of variant effects (MAVEs) guide clinical variant interpretation and reveal disease mechanisms. To date, MAVEs have focussed on a single mutation type-amino acid (AA) substitutions-despite the diversity of coding variants that cause disease. Here we use Deep Indel Mutagenesis (DIM) to generate a comprehensive atlas of diverse variant effects for a disease protein, the amyloid beta (Aβ) peptide that aggregates in Alzheimer's disease (AD) and is mutated in familial AD (fAD). The atlas identifies known fAD mutations and reveals that many variants beyond substitutions accelerate Aβ aggregation and are likely to be pathogenic. Truncations, substitutions, insertions, single- and internal multi-AA deletions differ in their propensity to enhance or impair aggregation, but likely pathogenic variants from all classes are highly enriched in the polar N-terminal region of Aβ. This comparative atlas highlights the importance of including diverse mutation types in MAVEs and provides important mechanistic insights into amyloid nucleation., M.S. was supported by a fellowship from Agencia de Gestio d’Ajuts Universitaris i de Recerca (2019FI_B 01311). Work in the lab of BB and BL is supported by the la Caixa Research Foundation project ‘DeepAmyloids’ (LCF/PR/HR21/52410004). Work in the lab of BB is also supported by the Spanish Ministry of Science, Innovation and Universities (PID2021-127761OB-I00 and RYC2020-028861-I, funded by MCIN/AEI/ 10.13039/501100011033, “ERDF A way of making Europe” and “ESF Investing in your future”) and the CERCA Program/Generalitat de Catalunya. Work in the lab of BL is also supported by a European Research Council (ERC) Advanced Grant (‘Mutanomics’ 883742), the Spanish Ministry of Science, Innovation and Universities (PID2020-118723GB-I00), the Bettencourt Schueller Foundation, the AXA Research Foundation, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership and the Centro de Excelencia Severo Ochoa. We thank the Chernoff lab for providing strains and plasmids and the CRG Genomics core technology for sequencing. We also thank Andre Faure and Marta Badia for advice on data analysis, Leire Moriones for assistance with validation experiments and Xavier Salvatella and Carla Garcia for discussing our data.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers

  • Park, Solip
  • Supek, Fran
  • Lehner, Ben, 1978-
The classic two-hit model posits that both alleles of a tumor suppressor gene (TSG) must be inactivated to cause cancer. In contrast, for some oncogenes and haploinsufficient TSGs, a single genetic alteration can suffice to increase tumor fitness. Here, by quantifying the interactions between mutations and copy number alterations (CNAs) across 10,000 tumors, we show that many cancer genes actually switch between acting as one-hit or two-hit drivers. Third order genetic interactions identify the causes of some of these switches in dominance and dosage sensitivity as mutations in other genes in the same biological pathway. The correct genetic model for a gene thus depends on the other mutations in a genome, with a second hit in the same gene or an alteration in a different gene in the same pathway sometimes representing alternative evolutionary paths to cancer., This work was funded by the European Research Council (ERC) Starting grant (HYPER-INSIGHT, 757700) to F.S. and ERC Consolidator (IR-DC, 616434) and Advanced (MUTANOMICS, 883742) grants to B.L. F.S. and B.L. are funded by the ICREA Research Professor program. S.P., F.S., and B.L. acknowledge the support of the Severo Ochoa Centres of Excellence program to the CNIO, IRB Barcelona, and to the CRG (MCIN/AEI/10.13039/50110001103), respectively. B.L. and F.S. Work is funded with the grants BFU2017-89488-P and RegioMut BFU2017-89833-P (MCIN/AEI /10.13039/501100011033/FEDER “A way to make Europe”), respectively. B.L. is further supported by the Bettencourt Schueller Foundation, the Agencia de Gestio d’Ajuts Universitaris i de Recerca (2017 SGR 1322), and the Centres de Recerca de Catalunya (CERCA) program/Generalitat de Catalunya. B.L. also acknowledges the support of the Spanish Ministry of Economy, Industry, and Competitiveness to the European Molecular Biology Laboratory (EMBL) partnership. The results shown here are in whole or part based upon data generated by the TCGA Research Network.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A small molecule stabilizer rescues the surface expression of nearly all missense variants in a GPCR

  • Mighell, Taylor L.
  • Lehner, Ben, 1978-
Data de publicació electrònica: 22-09-2025, Reduced protein abundance is the most frequent mechanism by which rare missense variants cause disease. A promising therapeutic avenue for treating reduced abundance variants is pharmacological chaperones (PCs, also known as correctors or stabilizers), small molecules that bind to and stabilize target proteins. PCs have been approved as clinical treatments for specific variants, but protein energetics suggest their effects might be much more general. To comprehensively assess PC efficacy for variation in a given protein, it is necessary to first assign the molecular mechanism explaining all pathogenic variants, then measure the response to the PC. Here we establish such a framework for the vasopressin 2 receptor (V2R), a G-protein-coupled receptor in which loss-of-function variants cause nephrogenic diabetes insipidus (NDI). Our data show that more than half of NDI variants are poorly expressed, highlighting loss of stability as the major pathogenic mechanism. Treatment with a PC rescues the expression of 87% of destabilized variants. The non-rescued variants identify the drug's predicted binding site. Our results provide proof-of-principle that small molecule binding can rescue destabilizing variants throughout a protein's structure. The application of this principle to other proteins should allow the development of effective therapies for many different rare diseases., This work was funded by a European Research Council Advanced Grant (883742), Wellcome (220540/Z/20/A), the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. T.L.M. was funded by an EMBO fellowship (ALTF 113-2021). We thank all members of the Lehner Lab and J. Selent and T. Stepniewski for helpful discussions. We thank the CRG/UPF Flow Cytometry Unit for assistance with the sorting experiments.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The energetic and allosteric landscape for KRAS inhibition

  • Weng, Chenchun
  • Faure, Andre J.
  • Escobedo, Albert
  • Lehner, Ben, 1978-
Thousands of proteins have been validated genetically as therapeutic targets for human diseases1. However, very few have been successfully targeted, and many are considered 'undruggable'. This is particularly true for proteins that function via protein-protein interactions-direct inhibition of binding interfaces is difficult and requires the identification of allosteric sites. However, most proteins have no known allosteric sites, and a comprehensive allosteric map does not exist for any protein. Here we address this shortcoming by charting multiple global atlases of inhibitory allosteric communication in KRAS. We quantified the effects of more than 26,000 mutations on the folding of KRAS and its binding to six interaction partners. Genetic interactions in double mutants enabled us to perform biophysical measurements at scale, inferring more than 22,000 causal free energy changes. These energy landscapes quantify how mutations tune the binding specificity of a signalling protein and map the inhibitory allosteric sites for an important therapeutic target. Allosteric propagation is particularly effective across the central β-sheet of KRAS, and multiple surface pockets are genetically validated as allosterically active, including a distal pocket in the C-terminal lobe of the protein. Allosteric mutations typically inhibit binding to all tested effectors, but they can also change the binding specificity, revealing the regulatory, evolutionary and therapeutic potential to tune pathway activation. Using the approach described here, it should be possible to rapidly and comprehensively identify allosteric target sites in many proteins., This work was funded by European Research Council (ERC) Advanced grant (883742), the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. C.W. was funded by an EMBO long-term fellowship (ALTF 881-2020). A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). We thank all members of the Lehner laboratory for helpful discussions and suggestions. We thank the CRG Genomics Unit for sequencing and the Protein Technologies Unit for assistance with the SPR measurements.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The impact of rare germline variants on human somatic mutation processes

  • Vali-Pour, Mischan
  • Lehner, Ben, 1978-
  • Supek, Fran
Somatic mutations are an inevitable component of ageing and the most important cause of cancer. The rates and types of somatic mutation vary across individuals, but relatively few inherited influences on mutation processes are known. We perform a gene-based rare variant association study with diverse mutational processes, using human cancer genomes from over 11,000 individuals of European ancestry. By combining burden and variance tests, we identify 207 associations involving 15 somatic mutational phenotypes and 42 genes that replicated in an independent data set at a false discovery rate of 1%. We associate rare inherited deleterious variants in genes such as MSH3, EXO1, SETD2, and MTOR with two phenotypically different forms of DNA mismatch repair deficiency, and variants in genes such as EXO1, PAXIP1, RIF1, and WRN with deficiency in homologous recombination repair. In addition, we identify associations with other mutational processes, such as APEX1 with APOBEC-signature mutagenesis. Many of the genes interact with each other and with known mutator genes within cellular sub-networks. Considered collectively, damaging variants in the identified genes are prevalent in the population. We suggest that rare germline variation in diverse genes commonly impacts mutational processes in somatic cells., M.V.P. was supported by a Spanish Ministry of Science and Innovation FPI Fellowship (ref.: PRE2018-084410). Work in the lab of B.L. is funded by European Research Council (ERC) Advanced (883742) and Consolidator (616434) grants, the Spanish Ministry of Science and Innovation (BFU2017-89488-P, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. Work in the lab of F.S. is funded by the ERC Starting Grant HYPER-INSIGHT (757700), the Horizon2020 RIA grant DECIDER (965193), Spanish Ministry of Science and Innovation grant REPAIRSCAPE (PID2020-118795GB-I00), the EMBO YIP program, the Severo Ochoa Centre of Excellence award to IRB Barcelona, and the CERCA Program/Generalitat de Catalunya. We thank Solip Park for method consultations, comments, and discussions.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Massive experimental quantification allows interpretable deep learning of protein aggregation

  • Thompson, Mike
  • Martín, Mariano
  • Sanmartín Olmo, Trinidad
  • Rajesh, Chandana
  • Koo, Peter K.
  • Bolognesi, Benedetta
  • Lehner, Ben, 1978-
Protein aggregation is a pathological hallmark of more than 50 human diseases and a major problem for biotechnology. Methods have been proposed to predict aggregation from sequence, but these have been trained and evaluated on small and biased experimental datasets. Here we directly address this data shortage by experimentally quantifying the aggregation of >100,000 protein sequences. This unprecedented dataset reveals the limited performance of existing computational methods and allows us to train CANYA, a convolution-attention hybrid neural network that accurately predicts aggregation from sequence. We adapt genomic neural network interpretability analyses to reveal CANYA's decision-making process and learned grammar. Our results illustrate the power of massive experimental analysis of random sequence-spaces and provide an interpretable and robust neural network model to predict aggregation., This work received support from the following: “La Caixa” Foundation (ID 100010434) under grant agreement LCF/PR/HR21/52410004 (B.L.); European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme grant agreement 883742 (B.L.); AXA Research Fund AXA Chair in Risk prediction in age-related diseases (B.L.); Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and the European Social Funds 2017 SGR 1322 (B.L.); Bettencourt Schueller Foundation (B.L.); PID2023-146685NB-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE; Wellcome 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026” (B.L.); Spanish Ministry of Science, Innovation and Universities PID2021-127761OB-I00 (B.B.) RYC2020-028861-I funded by MCIN/AEI/ 10.13039/501100011033 “ERDF A way of making Europe” and “ESF Investing in your future” (B.B.); European Union (ERC Consolidator, Glam-MAP, 101125484) (B.B.); EMBO Fellowship ALTF 266-2023 (M.T.); NIH grant R01HG012131 (P.K. and C.R.); and NIH grant R01GM149921 (P.K. and C.R.).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genetics, energetics, and allostery in proteins with randomized cores and surfaces

  • Escobedo, Albert
  • Voigt, Gesa
  • Faure, Andre J.
  • Lehner, Ben, 1978-
A lack of systematic experimental data limits our understanding of protein evolution. In this study, we experimentally characterized proteins with randomized sequences. Vast numbers of amino acid combinations constitute stable protein cores and surfaces. However, alternative cores frequently disrupt protein function by indirect allosteric effects. Both protein stability and binding can be predicted using simple additive energy models with a small contribution from pairwise energetic couplings. Indeed, energy models trained on one protein can predict functional cores and surfaces across more than a billion years of evolution, with only rare energetic couplings that we experimentally identify limiting the transplantation of cores between highly diverged proteins. Our results reveal the simple energetic architecture of proteins and suggest that allostery is an important constraint on sequence evolution., This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 883742), “la Caixa” Foundation under the grant agreement HR21-00375, the Bettencourt Schueller Foundation, the AXA Research Fund (AXA Chair in Risk prediction in age-related diseases), the Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia (AGAUR, 2017 SGR 1322), and Wellcome (Grant reference: 220540/Z/20/A, 'Wellcome Sanger Institute Quinquennial Review 2021-2026').
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Site-saturation mutagenesis of 500 human protein domains

  • Beltran, Antoni
  • Jiang, Xiang'er
  • Shen, Yue
  • Lehner, Ben, 1978-
Missense variants that change the amino acid sequences of proteins cause one-third of human genetic diseases1. Tens of millions of missense variants exist in the current human population, and the vast majority of these have unknown functional consequences. Here we present a large-scale experimental analysis of human missense variants across many different proteins. Using DNA synthesis and cellular selection experiments we quantify the effect of more than 500,000 variants on the abundance of more than 500 human protein domains. This dataset reveals that 60% of pathogenic missense variants reduce protein stability. The contribution of stability to protein fitness varies across proteins and diseases and is particularly important in recessive disorders. We combine stability measurements with protein language models to annotate functional sites across proteins. Mutational effects on stability are largely conserved in homologous domains, enabling accurate stability prediction across entire protein families using energy models. Our data demonstrate the feasibility of assaying human protein variants at scale and provides a large consistent reference dataset for clinical variant interpretation and training and benchmarking of computational methods., A.B. and B.L. were funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. A.B. was funded by an EMBO fellowship (ALTF 183-2020) and by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 101030961. X.J. and Y.S. were funded by the National Natural Science Foundation of China (32322047) and Jiangsu Provincial Department of Science and Technology (BM2023009). We thank all members of the Lehner laboratory for helpful discussions and suggestions.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

MoCHI: neural networks to fit interpretable models and quantify energies, energetic couplings, epistasis, and allostery from deep mutational scanning data

  • Faure, Andre J.
  • Lehner, Ben, 1978-
We present MoCHI, a tool to fit interpretable models using deep mutational scanning data. MoCHI infers free energy changes, as well as interaction terms (energetic couplings) for specified biophysical models, including from multimodal phenotypic data. When a user-specified model is unavailable, global nonlinearities (epistasis) can be estimated from the data. MoCHI also leverages ensemble, background-averaged epistasis to learn sparse models that can incorporate higher-order epistatic terms. MoCHI is freely available as a Python package ( https://github.com/lehner-lab/MoCHI ) relying on the PyTorch machine learning framework and allows biophysical measurements at scale, including the construction of allosteric maps of proteins., This work was funded by European Research Council (ERC) Advanced grant (883742), the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/https://doi.org/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The genetic architecture of protein interaction affinity and specificity

  • Bendel, Alexandra M.
  • Faure, Andre J.
  • Klein, Dominique
  • Shimada, Kenji
  • Lyautey, Romane
  • Schiffelholz, Nicole
  • Kempf, Georg
  • Cavadini, Simone
  • Lehner, Ben, 1978-
  • Diss, Guillaume
The encoding and evolution of specificity and affinity in protein-protein interactions is poorly understood. Here, we address this question by quantifying how all mutations in one protein, JUN, alter binding to all other members of a protein family, the 54 human basic leucine zipper transcription factors. We fit a global thermodynamic model to the data to reveal that most affinity changing mutations equally affect JUN's affinity to all its interaction partners. Mutations that alter binding specificity are relatively rare but distributed throughout the interaction interface. Specificity is determined both by features that promote on-target interactions and by those that prevent off-target interactions. Approximately half of the specificity-defining residues in JUN contribute both to promoting on-target binding and preventing off-target binding. Nearly all specificity-altering mutations in the interaction interface are pleiotropic, also altering affinity to all partners. In contrast, mutations outside the interface can tune global affinity without affecting specificity. Our results reveal the distributed encoding of specificity and affinity in an interaction interface and how coiled-coils provide an elegant solution to the challenge of optimizing both specificity and affinity in a large protein family.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Guidelines for releasing a variant effect predictor

  • Livesey, Benjamin J.
  • Badonyi, Mihaly
  • Dias, Mafalda
  • Frazer, Jonathan
  • Kumar, Sushant
  • Lindorff-Larsen, Kresten
  • McCandlish, David M.
  • Orenbuch, Rose
  • Shearer, Courtney A.
  • Muffley, Lara
  • Foreman, Julia
  • Glazer, Andrew M.
  • Lehner, Ben, 1978-
  • Marks, Debora S.
  • Roth, Frederick P.
  • Rubin, Alan F.
  • Starita, Lea M.
  • Marsh, Joseph A.
Computational methods for assessing the likely impacts of mutations, known as variant effect predictors (VEPs), are widely used in the assessment and interpretation of human genetic variation, as well as in other applications like protein engineering. Many different VEPs have been released, and there is tremendous variability in their underlying algorithms, outputs, and the ways in which the methodologies and predictions are shared. This leads to considerable difficulties for users trying to navigate the selection and application of VEPs. Here, to address these issues, we provide guidelines and recommendations for the release of novel VEPs., MD and J Frazer are supported by the Spanish Ministry of Science and Innovation (PID2022-140793NA-I00). KLL received funding from the Novo Nordisk Foundation (NNF18OC0033950). DMM received funding from the National Institutes of Health (NIH) (R35GM133613). RO and DSM are supported by the Chan Zuckerberg Initiative Neurodegeneration Challenge Network (CZI2018-191853). LM, LMS, and FPR received funding from the NIH (RM1HG010461), and FPR also received funding from NIH grant UM1HG011989. J Foreman received funding from the Wellcome Trust (WT223718/Z/21/Z). AMG received funding from the NIH (R35GM150465). BL received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 883742). DSM received funding from the NIH (1R01CA260415). AFR received funding from the NIH (UM1HG011969, RM1HG010461, R01HG013025) and grant funding from the Australian Government. JAM is supported by the ERC (grant agreement No. 101001169) and by the Medical Research Council (MRC) Human Genetics Unit core grant (MC_UU_00035/9).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The allosteric landscape of the Src kinase

  • Beltran, Antoni
  • Naqvi, Mohsin M.
  • Faure, Andre J.
  • Lehner, Ben, 1978-
Enzymes catalyze the reactions of life and are the targets of many drugs. Most inhibitors bind conserved active sites, frequently lacking specificity. Targeting allosteric sites can increase specificity, reduce toxicity, and allow fine-tuning of activity; however, most allosteric sites in enzymes are unmapped. Here, we present a comprehensive experimental allosteric map of the Src protein kinase. We quantify the effects of more than 50,000 single and double amino acid substitutions on activity and abundance and use thermodynamic modeling to disentangle changes in fold stability and catalysis. The comprehensive energy landscape reveals that allostery across the kinase domain is extensive, directionally biased, and modulated by its regulatory domains. Inhibitory-but not activating-allosteric mutations show a strong distance-dependent decay away from the active site. Using the map, we identify multiple potentially druggable allosteric sites not previously reported in Src or other kinases. Our results establish a framework for comprehensive mapping of allostery in kinases and other enzymes important for medicine and biotechnology., This work was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), the CERCA Program/Generalitat de Catalunya, and Wellcome (Grant reference: 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026”). A.B. was funded by an EMBO (ALTF 183-2020) and Marie Skłodowska-Curie (101030961) fellowship. A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI /10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). We thank all members of the Lehner laboratory for helpful discussions and suggestions.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

  • Baeza Centurión, Pablo, 1989-
  • Miñana Gómez, Belén
  • Faure, Andre J.
  • Thompson, Mike
  • Bonnal, Sophie
  • Quarantani, Gioia
  • Clarke, Joseph
  • Lehner, Ben, 1978-
  • Valcárcel, J. (Juan)
While altered pre-mRNA splicing is a frequent mechanism by which genetic variants cause disease, the regulatory architecture of human exons remains poorly understood. Antisense oligonucleotides (AONs) that target pre-mRNA splicing have been approved as therapeutics for various pathologies including patient-customised treatments for rare diseases, but AON discovery is currently slow and expensive, limiting the wider adoption of the approach. Here we show that deep indel mutagenesis (DIM) -which can be made experimentally at very low cost - provides an efficient strategy to chart the regulatory landscape of human exons and rapidly identify candidate splicing-modulating oligonucleotides. DIM reveals autonomous effects of insertions, while systematic deletion scans delineate the checkerboard architecture of sequential enhancers and silencers in a model alternative exon. The results also suggest a mechanism for repression of transmembrane domain-encoding exons and for the generation of microexons. Leveraging deep learning tools, we provide a resource, DANGO, that predicts the splicing regulatory landscape of all human exons and can help to identify effective splicing-modulating antisense oligonucleotides., This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreements 670146 and 883742) and from the European Union's Horizon Europe under the grant agreement No 101071936. We also acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. We received funding from the Spanish State Research Agency (PID2020-114630GB-I00/AEI/10.13039/501100011033), LCF/PR/HR21/52410004, EMBL Partnership, the Bettencourt Schueller Foundation, the AXA Research Fund, and Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322). GQ was supported by PRE2022-102744, financed by MCIN/AEI/10.13039/501100011033 and FSE + . J.C. is funded by the BBSRC DTP (Bio-technology and Biological Sciences Research Council, Biosciences Doctoral Training Programme, Cambridge, UK. The Genotype-Tissue Expression (GTEx) data used for the analyses described in this manu-script were obtained from the GTEx Portal on May 8, 2018 and dbGaP accession number phs000424.v7.p2 on May 8, 2018. The GTEx Project was supported by the Common Fund of the Office of the Director of the NIH and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Allostery is a widespread cause of loss-of-function variant pathogenicity

  • Liao, Xiaotian
  • Lehner, Ben, 1978-
Allosteric communication between non-contacting sites in proteins plays a fundamental role in biological regulation and drug action. While allosteric gain-of-function variants are known drivers of oncogene activation, the broader importance of allostery in genetic disease and protein evolution is less clear. Here, we introduce a comparative framework that disentangles functional disruption by mutations from protein destabilization. Applying this framework across diverse datasets-ranging from paired experimental measurements of abundance and activity to proteome-wide comparisons of evolutionary fitness and biophysical stability predictions-we provide evidence that allostery is a widespread cause of loss-of-function variant pathogenicity in human genetic diseases. In addition, our analyses reveal a conserved distance-dependent decay of allosteric mutational effects outside of protein active sites. As an important mechanism of pathogenicity, allostery needs to be better mapped, understood, and predicted across the human proteome., Work in the lab of B.L. was funded by Wellcome (Grant reference: 220540/Z/20/A, 'Wellcome Sanger Institute Quinquennial Review 2021-2026'), a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Center of Excellence), Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR, 2021 SGR 01226), and the CERCA Program/Generalitat de Catalunya. X.L is funded by the Wellcome Sanger Institute PhD Graduate program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Massively parallel genetic perturbation suggests the energetic structure of an amyloid-β transition state

  • Arutyunyan, Anna
  • Seuma, Mireia
  • Faure, Andre J.
  • Bolognesi, Benedetta
  • Lehner, Ben, 1978-
Amyloid aggregates are pathological hallmarks of many human diseases, but how soluble proteins nucleate to form amyloids is poorly understood. Here, we use combinatorial mutagenesis, a kinetic selection assay, and machine learning to massively perturb the energetics of the nucleation reaction of amyloid-β (Aβ42), the protein that aggregates in Alzheimer's disease. In total, we measure the nucleation rates of >140,000 variants of Aβ42 to accurately quantify the changes in free energy of activation of the reaction for all possible amino acid substitutions in a protein and, in addition, to quantify >600 energetic interactions between mutations. Strong energetic couplings suggest that the Aβ42 nucleation reaction transition state is structured in a short C-terminal region, providing a structural model for the reaction that may initiate Alzheimer's disease. Using this approach it should be possible to reveal the energetic structures of additional amyloid transition states and, in combination with additional selection assays, protein transition states more generally., This work was funded by the La Caixa Research Foundation project “DeepAmyloids” (LCF/PR/HR21/52410004). Work in the lab of B.B. was also funded by the Spanish Ministry of Science, Innovation and Universities (PID2021-127761OB-I00 and RYC2020-028861-I funded by MCIN/AEI/10.13039/501100011033, “ERDF A way of making Europe” and “ESF Investing in your future”) and by the European Union (ERC Consolidator, Glam-MAP, 101125484). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. Work in the lab of B.L. was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), the CERCA Program/Generalitat de Catalunya, and Wellcome (grant reference: 220540/Z/20/A, “Wellcome Sanger Institute Quinquennial Review 2021-2026”). M.S. was funded by a fellowship from Agencia de Gestio d’Ajuts Universitaris i de Recerca (2019FI_B 01311). A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Allosteric and energetic remodeling of a PDZ domain by protein domain extensions

  • Hidalgo-Carcedo, Cristina
  • Faure, Andre J.
  • Martí-Aranda, Aina
  • Zarin, Taraneh
  • Lehner, Ben, 1978-
Many functions of proteins are performed by independently folding structural units called domains. These domains are structurally conserved but not identical in different proteins. Here, to understand the consequences for regulation and evolvability of domain extensions, we quantify the energetic effects of two extensions in a model protein domain. Quantifying abundance and ligand binding for >190,000 protein variants allows us to measure the free energy changes for mutations throughout a PDZ domain and ~7000 energetic couplings between these mutations and two domain extensions. Both a structured extension and a more dynamic extension substantially but specifically re-shape the energy landscape. In particular, deleting an a-helix alters the energetic consequences of >400 mutations in >50 sites on fold stability or binding energy, and the effects of >300 allosteric mutations, including at solvent-accessible surface sites. Extending or pruning the domain therefore reshapes its energetic and allosteric landscape, adding and removing opportunities for the allosteric control of protein function., These results are part of project PID2022-142210NA-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE. This work has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 883742), the Spanish State Research Agency (PID2020-118723GB-I00/ AEI / 10.13039/501100011033), Wellcome (220540/Z/20/A), Departament de Recerca i Universitats de la Generalitat de Catalunya (AGAUR, 2021-SGR2021-01226). A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). A.M.A. was funded in part by a fellowship from 'laCaixa' Foundation (ID 100010434, fellowship code B006052). T.Z. was funded by a EMBO Long-term Postdoctoral Fellowship (ALTF 525-2021) and the European Union's Horizon Europe under the grant agreement No 101068134. We acknowledge support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. We acknowledge all members of the Lehner lab for feedback during the project, particularly Toni Beltran and Albert Escobedo for advice with data analysis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The genetic architecture of protein stability

  • Faure, Andre J.
  • Martí Aranda, Aina
  • Hidalgo-Carcedo, Cristina
  • Beltran, Antoni
  • Schmiedel, Jörn M.
  • Lehner, Ben, 1978-
There are more ways to synthesize a 100-amino acid (aa) protein (20100) than there are atoms in the universe. Only a very small fraction of such a vast sequence space can ever be experimentally or computationally surveyed. Deep neural networks are increasingly being used to navigate high-dimensional sequence spaces1. However, these models are extremely complicated. Here, by experimentally sampling from sequence spaces larger than 1010, we show that the genetic architecture of at least some proteins is remarkably simple, allowing accurate genetic prediction in high-dimensional sequence spaces with fully interpretable energy models. These models capture the nonlinear relationships between free energies and phenotypes but otherwise consist of additive free energy changes with a small contribution from pairwise energetic couplings. These energetic couplings are sparse and associated with structural contacts and backbone proximity. Our results indicate that protein genetics is actually both rather simple and intelligible., This work was funded by a European Research Council Advanced Grant (883742), the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. A.J.F. was funded by a Ramón y Cajal fellowship (RYC2021-033375-I) financed by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033) and the European Union (NextGenerationEU/PRTR). A.M.-A. was funded by a fellowship from ”laCaixa” Foundation (ID 100010434, fellowship code B006052). We thank all members of the Lehner Lab for helpful discussions and suggestions.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The impact of rare germline variants on human somatic mutation processes

  • Vali-Pour, Mischan
  • Solip, Park
  • Espinosa-Carrasco, José
  • Ortiz-Martínez, Daniel
  • Lehner, Ben, 1978-
  • Supek, Fran
Somatic mutations are an inevitable component of ageing and the most important cause of cancer. The rates and types of somatic mutation vary across individuals, but relatively few inherited influences on mutation processes are known. We perform a gene-based rare variant association study with diverse mutational processes, using human cancer genomes from over 11,000 individuals of European ancestry. By combining burden and variance tests, we identify 207 associations involving 15 somatic mutational phenotypes and 42 genes that replicated in an independent data set at a false discovery rate of 1%. We associate rare inherited deleterious variants in genes such as MSH3, EXO1, SETD2, and MTOR with two phenotypically different forms of DNA mismatch repair deficiency, and variants in genes such as EXO1, PAXIP1, RIF1, and WRN with deficiency in homologous recombination repair. In addition, we identify associations with other mutational processes, such as APEX1 with APOBEC-signature mutagenesis. Many of the genes interact with each other and with known mutator genes within cellular sub-networks. Considered collectively, damaging variants in the identified genes are prevalent in the population. We suggest that rare germline variation in diverse genes commonly impacts mutational processes in somatic cells., M.V.P. was supported by a Spanish Ministry of Science and Innovation FPI Fellowship (ref.: PRE2018-084410). Work in the lab of B.L. is funded by European Research Council (ERC) Advanced (883742) and Consolidator (616434) grants, the Spanish Ministry of Science and Innovation (BFU2017-89488-P, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. Work in the lab of F.S. is funded by the ERC Starting Grant HYPER-INSIGHT (757700), the Horizon2020 RIA grant DECIDER (965193), Spanish Ministry of Science and Innovation grant REPAIRSCAPE (PID2020-118795GB-I00), the EMBO YIP program, the Severo Ochoa Centre of Excellence award to IRB Barcelona, and the CERCA Program/Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deep indel mutagenesis reveals the impact of amino acid insertions and deletions on protein stability and function

  • Topolska, Magdalena
  • Beltran, Antoni
  • Lehner, Ben, 1978-
Amino acid insertions and deletions (indels) are an abundant class of genetic variants. However, compared to substitutions, the effects of indels on protein stability are not well understood. To better understand indels here we analyse new and existing large-scale deep indel mutagenesis (DIM) of structurally diverse proteins. The effects of indels on protein stability vary extensively among and within proteins and are not well predicted by existing computational methods. To address this shortcoming we present INDELi, a series of models that combine experimental or predicted substitution effects and secondary structure information to provide good prediction of the effects of indels on both protein stability and pathogenicity. Moreover, quantifying the effects of indels on protein-protein interactions suggests that insertions can be an important class of gain-of-function variants. Our results provide an overview of the impact of indels on proteins and a method to predict their effects genome-wide., This work was funded by a European Research Council (ERC) Advanced (883742) grant, the Spanish Ministry of Science and Innovation (LCF/PR/HR21/52410004, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Programme/Generalitat de Catalunya. M.T. was funded by a Spanish Ministry of Science and Innovation Severo-Ochoa fellowship PRE2020-093984-SO. T.B. was funded by an EMBO (ALTF 183-2020) and Marie Skłodowska-Curie (101030961) fellowship.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mapping the energetic and allosteric landscapes of protein binding domains.

  • Faure, Andre J.
  • Domingo Espinós, Júlia, 1991-
  • Schmiedel, Jörn M.
  • Hidalgo-Carcedo, Cristina
  • Diss, Guillaume
  • Lehner, Ben, 1978-
Allosteric communication between distant sites in proteins is central to biological regulation but still poorly characterized, limiting understanding, engineering and drug development1-6. An important reason for this is the lack of methods to comprehensively quantify allostery in diverse proteins. Here we address this shortcoming and present a method that uses deep mutational scanning to globally map allostery. The approach uses an efficient experimental design to infer en masse the causal biophysical effects of mutations by quantifying multiple molecular phenotypes-here we examine binding and protein abundance-in multiple genetic backgrounds and fitting thermodynamic models using neural networks. We apply the approach to two of the most common protein interaction domains found in humans, an SH3 domain and a PDZ domain, to produce comprehensive atlases of allosteric communication. Allosteric mutations are abundant, with a large mutational target space of network-altering 'edgetic' variants. Mutations are more likely to be allosteric closer to binding interfaces, at glycine residues and at specific residues connecting to an opposite surface within the PDZ domain. This general approach of quantifying mutational effects for multiple molecular phenotypes and in multiple genetic backgrounds should enable the energetic and allosteric landscapes of many proteins to be rapidly and comprehensively mapped., This work was funded by European Research Council (ERC) Advanced (883742) and Consolidator (616434) grants, the Spanish Ministry of Science and Innovation (PID2020-118723GB-I00, BFU2017-89488-P, EMBL Partnership, Severo Ochoa Centre of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. J.M.S. was supported by an EMBO Long-Term Fellowship (ALTF 857-2016) and a Marie Skłodowska-Curie Fellowship (752809, EU Commission Horizon 2020)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules

  • Toledano, Ignasi
  • Supek, Fran
  • Lehner, Ben
Premature termination codons (PTCs) cause ~10-20% of inherited diseases and are a major mechanism of tumor suppressor gene inactivation in cancer. A general strategy to alleviate the effects of PTCs would be to promote translational readthrough. Nonsense suppression by small molecules has proven effective in diverse disease models, but translation into the clinic is hampered by ineffective readthrough of many PTCs. Here we directly tackle the challenge of defining drug efficacy by quantifying the readthrough of ~5,800 human pathogenic stop codons by eight drugs. We find that different drugs promote the readthrough of complementary subsets of PTCs defined by local sequence context. This allows us to build interpretable models that accurately predict drug-induced readthrough genome-wide, and we validate these models by quantifying endogenous stop codon readthrough. Accurate readthrough quantification and prediction will empower clinical trial design and the development of personalized nonsense suppression therapies., Work in the Supek laboratory was supported by an ERC StG ‘HYPER-INSIGHT’ (757700) and ERC CoG ‘STRUCTOMATIC’ (101088342), Horizon2020 project ‘DECIDER’ (965193), Horizon Europe project ‘LUCIA’ (101096473), Spanish government project ‘REPAIRSCAPE’, CaixaResearch project ‘POTENT-IMMUNO’ (HR22-00402), an ICREA professorship to F.S., the SGR funding from the Catalan government and a Novo Nordisk Fonden starting package. Work in the Lehner laboratory was funded by European Research Council (ERC) Advanced (grant 883742) and Consolidator (grant 616434), the Spanish Ministry of Science and Innovation (BFU2017-89488-P, EMBL Partnership, Severo Ochoa Center of Excellence), the Bettencourt Schueller Foundation, the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322) and the CERCA Program/Generalitat de Catalunya. The authors would like to thank the four members E. Ramírez, A. Bote, E. Julià and Ò. Fornàs of the Flow Cytometry CRG Core Unit for their support and time, together with G. Palou (IRB) for his help in retrieving the transcript sequences from the Ensembl database and all members of the Supek and Lehner laboratories for helpful discussions and suggestions.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

SUNi mutagenesis: Scalable and uniform nicking for efficient generation of variant libraries

  • Mighell, Taylor L.
  • Toledano, Ignasi
  • Lehner, Ben, 1978-
Multiplexed assays of variant effects (MAVEs) have made possible the functional assessment of all possible mutations to genes and regulatory sequences. A core pillar of the approach is generation of variant libraries, but current methods are either difficult to scale or not uniform enough to enable MAVEs at the scale of gene families or beyond. We present an improved method called Scalable and Uniform Nicking (SUNi) mutagenesis that combines massive scalability with high uniformity to enable cost-effective MAVEs of gene families and eventually genomes., This work was funded by a European Research Council (ERC) Advanced grant (883742), the Spanish Ministry of Science and Innovation (PID2020-118723GB-I00, EMBL Partnership, Severo Ochoa Centre of Excellence), the la Caixa Research Foundation (LCF/PR/HR21/52410004), the AXA Research Fund, Agencia de Gestio d’Ajuts Universitaris i de Recerca (AGAUR, 2017 SGR 1322), and the CERCA Program/Generalitat de Catalunya. T.L.M. was funded by an EMBO long-term fellowship (ALTF 113-2021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.